Anondita Medicare SME
smeListed
GMP
₹89
smeListed
Anondita Medicare SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹89
(+61.38%) Est. Gain
Investment Timeline
✓
IPO Open
22 Aug 2025
✓
IPO Close
26 Aug 2025
✓
Allotment
28 Aug 2025
✓
Listing
1 Sept 2025
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
APPLY
74.4/100
🎯 Application Strategy
Action: ✅ APPLY - Strong opportunity with good risk-reward
Lots: Apply 2-3 lots or maximum affordable
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
🚀 Exceptional subscription! Massive oversubscription across all categories
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
🎯 Very high listing gain potential (20%+ expected)
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹137.00-145.00
📦Lot Size
1000 shares
💰Issue Size
₹65.58 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of Anondita Medicare SME?
As of today, the Grey Market Premium (GMP) for Anondita Medicare SME is ₹89, which is approximately (+61.38%) of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for Anondita Medicare SME?
Our AI algorithm currently rates this IPO as "APPLY" with a score of 74.4/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for Anondita Medicare SME be announced?
The allotment status for Anondita Medicare SME is expected to be finalized on 28 Aug 2025. Investors can check their status on the registrar's website.
What is the listing date for Anondita Medicare SME?
Shares of Anondita Medicare SME are proposed to be listed on stock exchanges on 1 Sept 2025.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.